Castelhano, Arlindo L.,Engers, David A.,Hanko, Jason A.,Rechka, Josef A.,Teng, Jing,Yang, Yonglai
申请号：
AU2011270890
公开号：
AU2011270890A1
申请日:
2011.06.23
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
Polymorphic forms of the tyrosine kinase inhibitor OSI-906, preparation, pharmaceutical compositions, and uses thereof. The invention includes methods of treating diseases such as cancer, including cancer mediated at least in part by IGF-1 R and/or IR, with the polymorphs and compositions. This Abstract is not limiting of the invention.
